Cynthia Hope
Psychiatry · Mt Pleasant, SCNPI 1942491261
Payments from drug & device makers
Across 146 payments — averaging $18.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$436
- Axsome Therapeutics, Inc.$318
- Otsuka America Pharmaceutical, Inc.$274
- Almatica Pharma LLC$182
- Sunovion Pharmaceuticals Inc.$172
- Vanda Pharmaceuticals Inc.$151
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $436 |
| Axsome Therapeutics, Inc. | 13 | $318 |
| Otsuka America Pharmaceutical, Inc. | 16 | $274 |
| Almatica Pharma LLC | 10 | $182 |
| Sunovion Pharmaceuticals Inc. | 8 | $172 |
| Vanda Pharmaceuticals Inc. | 8 | $151 |
| Bausch Health US, LLC | 7 | $138 |
| Lundbeck LLC | 5 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $111 |
| Johnson & Johnson | 7 | $104 |
| Corium, LLC | 9 | $93 |
| Ironshore Pharmaceuticals Inc. | 5 | $84 |
| Alkermes, Inc. | 5 | $83 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $80 |
| E.r. Squibb & Sons, L.L.C. | 2 | $48 |
| Neos Therapeutics, LP | 3 | $48 |
| Neurocrine Biosciences, Inc. | 2 | $46 |
| Tris Pharma Inc | 2 | $41 |
| Harmony Biosciences LLC | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $32 |
| Alfasigma USA, Inc. | 2 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
How this compares
$2,666 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 43 | $1,647 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 63 | $1,256 |
| Bupropion XlBupropion Hcl | 27 | $837 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 18 | $582 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 24 | $479 |
| Methylphenidate Hcl | 21 | $341 |
| Mirtazapine | 16 | $317 |
| Lamotrigine | 15 | $314 |
| Quetiapine Fumarate | 13 | $313 |
| Bupropion Hcl SrBupropion Hcl | 13 | $307 |
| Clonazepam | 58 | $264 |
| Fluoxetine Hcl | 30 | $262 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $201 |
| Gabapentin | 19 | $187 |
| Escitalopram Oxalate | 14 | $150 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Mt Pleasant
- Khoa VoMt Pleasant$21K
- Jacobo MintzerCharleston$4.9M
- Paul RobbinsSummerville$1.2M
- Brittany AlbrightMount Pleasant$691K
- Eduardo CifuentesCharleston$675K
- Veronica RidpathFlorence$364K
- Mark GeorgeCharleston$332K
- Jagdish ShahRock Hill$320K
- Ricardo FermoCharleston$262K
- John DewittAiken$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.